Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Berek

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
The New England Journal of Medicine|October 9, 2016
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian CancerMansoor R Mirza, Bradley J Monk, Jørn Herrstedt, et al.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
Gynecologic Oncology|June 4, 2024
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO studyVicky Makker, Jose Alejandro Perez-Fidalgo, Giorgio Valabrega, et al.
The Lancet. Oncology|July 28, 2022
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroupIgnace Vergote, Antonio Gonzalez-Martin, Domenica Lorusso, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
Journal of Minimally Invasive Gynecology|January 17, 2016
An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine MyomasWilliam Parker, Jonathan S Berek, Elizabeth Pritts, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
The New England Journal of Medicine|October 9, 2016
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian CancerMansoor R Mirza, Bradley J Monk, Jørn Herrstedt, et al.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
Gynecologic Oncology|June 4, 2024
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO studyVicky Makker, Jose Alejandro Perez-Fidalgo, Giorgio Valabrega, et al.
The Lancet. Oncology|July 28, 2022
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroupIgnace Vergote, Antonio Gonzalez-Martin, Domenica Lorusso, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
Journal of Minimally Invasive Gynecology|January 17, 2016
An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine MyomasWilliam Parker, Jonathan S Berek, Elizabeth Pritts, et al.
Pageof 14